Hair loss drugs are the next Ozempic. Biotech stocks are climbing
Shares of US-based Veradermics have climbed nearly 500 per cent since the company went public in February this year.
Shares of US-based Veradermics have climbed nearly 500 per cent since the company went public in February this year.
What's Your Reaction?
